Remote screening yielded new cases of atrial fibrillation (Afib or AF) in the general population that otherwise would have ...

The analysis period corresponded to the initial launch of the Zio monitor and included 14-day prescriptions between May 2022 and September 2023, comprising 7,433 Zio monitors and 1,336,391 Zio XT ...

A remote screening strategy for asymptomatic atrial fibrillation involving use of an ECG patch for continuous ambulatory monitoring conferred a modest increase in AF diagnoses after 2.5 years among ...

The analysis period corresponded to the initial launch of Zio monitor and included 14-day prescriptions between May 2022 and September 2023, comprising 7,433 Zio monitors and 1,336,391 Zio XT devices.

The Zio XT adhesive patch was worn on the chest for a median 27.4 out of 28 days. Adverse skin reactions leading to premature discontinuation of ECG monitoring occurred in 1.2% of study participants.

Currently, IRTC's offerings include patch monitors called Zio XT and Zio AT, which have proven to have high patient compliance and yield accurate diagnostic results.

iRhythm is launching its next generation long-term ambulatory cardiac monitor in the U.S. Zio ® monitor builds on the high performance of Zio® XT that, together with its enhanced Zio® long term ...

iRhythm’s next-generation Zio® monitor demonstrated longer wear duration and analyzable time compared to the prior generation Zio® XT device.

The trial was sponsored by Bristol-Myers Squibb-Pfizer Alliance and iRhythm provided the Zio XT patch ECG long-term continuous monitoring (LTCM) monitor used in the interventional (screening) arm ...

The new model is made to be significantly smaller, thinner and lighter compared to the company’s previous Zio XT ECG-recording patch.

In a small study of 30 patients conducted by researchers from four Washington state-based institutions, a team directly compared the readings of iRhythm’s Zio XT to Bardy Diagnostics’ Carnation ...